Skip to content

Clinical study of effectiveness of Korean bioceramic cement

Clinical study of the effectiveness of next-generation vital pulp therapy using premixed single paste-type Korean bioceramic cement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008057
Enrollment
100
Registered
2022-12-30
Start date
2022-12-19
Completion date
Unknown
Last updated
2023-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : The intervention group in this study is ENDOCEM MTA Premixed, a calcium silicate cement used for vital pulp treatment because of deep caries. A one-time treatment is possible, and it

Sponsors

Jeonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Age of selected candidates: Adult men and women over 19 years of age - Selected teeth: Permanent teeth whose pulp is exposed due to dental caries - Clinical symptoms: Normal range of mobility and response to percussion / No unspecified pain / Hemostasis within minutes with wet cotton after pulpotomy - Radiographic finding: No root resorption observed / No radiolucent lesions observed at the apical end and at the root bifurcation - Others: Final restoration with composite resin or indirect restoration must be possible.

Exclusion criteria

Exclusion criteria: - Clinical symptoms: sustained pain (spontaneous pain) / abnormal range of mobility and response to percussion / gingival fistula, swelling observed / No response of pulp vitality / No-hemostasis within minutes with wet cotton after pulpotomy - Radiographic findings: root resorption observed / radiolucent bone resorption lesions observed at apical end and root bifurcation - Others: when final restoration is not possible / patients with systemic diseases for whom normal dental treatment and postoperative examination are difficult / pregnant women and lactating women

Design outcomes

Primary

MeasureTime frame
Safety of use of ENDOCEM MTA Premixed

Secondary

MeasureTime frame
Efficacy of use of ENDOCEM MTA Premixed

Countries

Korea, Republic of

Contacts

Public ContactSieun Nam

Jeonbuk National University Hospital

sieun328@naver.com+82-63-250-2119

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026